CTOs on the Move

National Clinical Research

www.ncrinc.net

 
National Clinical Research is a Richmond, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.ncrinc.net
  • 1400 Westwood Ave
    Richmond, VA USA 23227
  • Phone: 804.672.2995

Executives

Name Title Contact Details

Similar Companies

Camtec

Camtec is a Cambridge, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Feinstein Kean Healthcare

Feinstein Kean Healthcare is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Cambridge, MA. To find more information about Feinstein Kean Healthcare, please visit www.fkhealth.com

AllerVie

AllerVie Health is a national network of board-certified allergists and immunologists partnering together for the advancement of patient care, serving patients across 12 states in 76 clinic locations. Our providers are committed to establishing the allergy and immunology gold standard, expanding access to best-in-class care, and bringing relief and renewed vitality to the millions of Americans affected annually, many of whom live in underserved communities today. AllerVie is relentlessly dedicated to clinical excellence, creating an improved patient experience, and supporting the development of advanced allergy and immunology-focused therapeutics and treatment options. With AllerVie Health, our patients can feel their best, reclaim their lives, and live in freedom!

Berg LLC

BERG is a Boston-based biopharma company focused on taking a bold “back to biology” approach to therapeutic discovery using its unique AI-based Interrogative Biology® platform. This platform combines patient biology and AI-based analytics to engage the differences between healthy and disease environments. The patient’s own biology drives the platform’s results and guides us in the discovery and development of drugs, diagnostics and healthcare applications. Our platform utilizes patient population health data to bring actionable Patient IntelligenceTM to precision medicine applications. For patients this means faster discovery and development of treatments, more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems. BERG has a robust product portfolio in oncology, endocrinology and neurology with mature assets in oncology entering mid and late stage trials. BERG is committed to improving the lives of patients through precision medicine made possible by our innovative platforms.

Call9

Call9 is a technology company innovating medical services and systems in EmergencyMedicine and PalliativeCare.